Sy. Huang et al., EXPRESSION OF THE JE MCP-1 GENE SUPPRESSES METASTATIC POTENTIAL IN MURINE COLON-CARCINOMA CELLS/, Cancer immunology and immunotherapy, 39(4), 1994, pp. 231-238
The purpose of this study was to determine whether the expression of t
he JE/MCP-1 gene encoding for the monocyte chemottractant protein, MCP
-1 (also known as monocyte chemotactic and activating factor MCAF TDCF
and SMC-CF) can influence the metastatic properties of tumor cells. T
he highly metastatic murine colon carcinoma CT-26 cells, syngeneic to
BALB/c mice that do not produce endogenous JE/MCP-1 protein, were tran
sfected with a BCMGS-Neo expression vector (control) or a vector conta
ining full-length JE cDNA. CT-26 parental cells, CT-26 Neo, and CT-26
JE/MCP-1-positive cells were injected into syngeneic or nude mice. The
CT-26 JE/MCP-positive cells produced significantly fewer lung metasta
ses. The decrease in incidence of metastasis was not due to the inabil
ity of the transfected cells to arrest in the lung vasculature or to d
ifferences in cell cycle time. CT-26 cells producing JE/MCP-1 were hig
hly susceptible to lysis by syngeneic macrophages treated with subthre
shold concentrations of lipopolysaccharide. In addition, culture super
natants of JE/MCP-1-expressing cells plus lipopolysaccharide synergist
ically activated tumoricidal properties in syngeneic macrophages. This
activity was blocked by anti-JE/MCP-1 antibodies, indicating the invo
lvement of the JE/MCP-1 molecule in this process. Moreover, purified J
E/MCP-1 added to lipopolysaccharide-containing medium resulted in sign
ificant activation of macrophages against parental CT-26 cells. These
data suggest that, in addition to its chemotactic properties, JE/MCP-1
can synergize with bacterial endotoxins to activate macrophages to be
come tumoricidal and, hence, could suppress metastasis.